A definitive diagnosis and differentiation from other connective tissue disorders can be established through genetic testing, which identifies mutations in the ZNF469 gene (Type 1) and PRDM5 gene (Type 2) [3,4,5,6,9,10]. Here, ZNF469 is linked to connective tissue disorder.